Prot# CLBH589B2201: A Phase II Study of Oral LBH589 in Adult Patients with Refractory Cutaneous T-Cell Lymphoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/13/07 → 10/1/11

Funding

  • Novartis Pharmaceuticals Corporation (CLBH589B2201)